Literature DB >> 19538827

High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B.

N Antaki1, S Haffar, S Ali Deeb, F Assaad, R Abou Harb, N Zeibane, M Nasserelddine, N Ibrahim, N Alhaj, E Jabbour, R Aaraj, F Antaki, K Kebbewar.   

Abstract

Hepatitis B virus (HBV) genotype D and hepatitis B e antigen (HBeAg) negative chronic hepatitis are the most prevalent in Mediterranean countries. No data have ever been published on their prevalence in Syria, a country of intermediate endemicity for HBV. The aims of the current study were to determine the HBV genotype distribution in Syria, the prevalence of HBeAg-positive and HBeAg-negative chronic hepatitis and to analyse the clinical characteristics of each group. A total of 220 patients were included. Ninety-seven percent of the patients were of genotype D, and 72% were HBeAg negative. The HBeAg-negative patients were older, had a lower viral load, had more cirrhosis and the mode of contamination was known less than for HBeAg-positive patients. These findings have major implications in understanding the natural history of the infection and are of great relevance in the choice of therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538827     DOI: 10.1017/S0950268809990288

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  4 in total

1.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

2.  Subgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestine.

Authors:  Zakeih Abdelnabi; Niveen Saleh; Sabri Baraghithi; Dieter Glebe; Maysa Azzeh
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  Hepatitis B splice-generated protein antibodies in Syrian chronic hepatitis B patients: incidence and significance.

Authors:  Nour Al-Hanafi; Fawza Monem
Journal:  Hepat Mon       Date:  2014-04-16       Impact factor: 0.660

4.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.